Tech & industry
Researchers at Northwell Health’s Feinstein Institutes for Medical Research have developed an AI-based tool that identifies a brain metabolic network capable of predicting psychosis in Alzheimer's disease (AD). This discovery offers a potential breakthrough for earlier diagnosis, treatment development and personalised medicine for individuals with AD. The study, led by Jeremy L. Koppel, associate professor [...]
A new study has revealed that digital technologies are associated with reduced cognitive decline. The study was sparked by the ongoing concern about the passive activity of digital technologies and their relation to accelerating risks of dementia. The “digital dementia” hypothesis predicts that a lifetime of exposure to digital technology will worsen cognitive abilities. On [...]
Certified speech pathologist and neuromuscular electrical stimulation device practitioner, Vanessa Abraham, who has had her own experience with a rare and progressive neurological disease, supports neurological patients recovering from neurological disorders, medical trauma, and the accompanying mental health challenges. With over 15 years of experience in schools, Abraham has worked with children to help them [...]
Neurotech company Reneural is partnering with The Hillingdon Hospitals NHS Foundation Trust and Brunel University of London, to bring VR stroke rehabilitation to patients. Reneural has been awarded funding through the New Hospital Programme by NHS England to further develop its digital health solution for stroke rehabilitation. The collaboration brings together leading experts across healthcare [...]
Neuro Rehab Times explores the latest developments in the world of neurotechnology. Building next-generation brain/neural-machine interfaces for restoration of brain functions CORDIS - EU research has reported results on research into adaptive neurotech which aims to restore body and brain functions. NGBMI, which received funding from the European Union’s Horizon 2020 research and innovation programme, [...]
Digital software company Strolll has raised £10.35m to advance its augmented reality (AR) glasses for neuro-rehab to patients living with neurological disorders. Strolll's platform combines digital content with the real world through the use of off-the-shelf AR glasses that are aimed at helping people living with neurological disorders such as Parkinson’s disease, stroke, and multiple [...]
Neuro Rehab Times explores the latest developments in the world of neurotech. New MRI technique can help predict and guide stroke patients’ recovery A new Georgetown University Medical Center study in collaboration with MedStar Health and the National Institutes of Health exploring a new brain imaging technique is bringing stroke experts a step closer to [...]
People with (MND) who can no longer communicate through speech or eye movement can now use the power of thought to indicate ‘yes’ or ‘no’ thanks to a new brainwave reader developed by Nottingham Trent University (NTU). The brainwave reader has been made affordable by using off-the-shelf parts and a novel artificial intelligence (AI) algorithm [...]
NR Times explores the latest advancements in neurotechnology. First trial of innovative stent for Treating Idiopathic Intracranial Hypertension Serenity Medical, a NeuroTechnology Investors (NTI) portfolio company, has announced the publication of The River Study: the first multicentre trial of a novel venous sinus stent for the treatment of Idiopathic Intracranial Hypertension (IIH). The publication reports [...]
The PoNS Therapeutic Experience Program, which utilises an innovative device on the tongue, has shown significant improvements for gait rehabilitation in people with Multiple Sclerosis. Researchers say the results mark an important step forward in understanding the role of neuromodulation and neuroplasticity in gait function. PoNS therapy - short for Portable Neuromodulation Stimulator - uses [...]
